EUVIMEDEUVIMED entdecken
Crossref

Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits

Ehud Mekori-Domachevsky, Michal Taler, Yehuda Shoenfeld, Michael Gurevich, Polina Sonis, Omri Weisman, Abraham Weizman, Doron Gothelf

The Journal of Clinical Psychiatry · 27.12.2017 · 78 (9) · e1219-e1225

DOI: 10.4088/jcp.16m11207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, erschienen am 27.12.2017. Verfasst von Ehud Mekori-Domachevsky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral Neurogenetics Center, The Child Psychiatry Unit, Sheba Medical Center, 52621, Tel Hashomer, Israel. ehud.mekori@sheba.health.gov.il. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAdultC-Reactive ProteinCase-Control StudiesChildCognitive DysfunctionDiGeorge SyndromeFemaleHumansInflammationInterleukin-10Interleukin-6MalePsychotic DisordersTumor Necrosis Factor-alphaYoung Adult

Substanzen

Interleukin-6Tumor Necrosis Factor-alphaInterleukin-10C-Reactive Protein

Autor:innen und Institutionen

  • Behavioral Neurogenetics Center, The Child Psychiatry Unit, Sheba Medical Center, 52621, Tel Hashomer, Israel. ehud.mekori@sheba.health.gov.il.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Behavioral Neurogenetics Center, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Petah Tikva, Israel.
  • Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
  • Functional Genomics and Neurogenomics, Sheba Medical Center, Tel Hashomer, Israel.

Förderung

  • NIMH NIH HHS

Zitieren

APA

Mekori-Domachevsky, E., Taler, M., Shoenfeld, Y., Gurevich, M., Sonis, P., Weisman, O., Weizman, A., & Gothelf, D. (2017). Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits. The Journal of Clinical Psychiatry, 78(9), e1219-e1225. https://doi.org/10.4088/jcp.16m11207

Vancouver

Mekori-Domachevsky E, Taler M, Shoenfeld Y, Gurevich M, Sonis P, Weisman O, et al. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits. The Journal of Clinical Psychiatry. 2017;78(9):e1219-e1225. doi:10.4088/jcp.16m11207

BibTeX
@article{MekoriDomachevsky2017,
  author = {Mekori-Domachevsky, Ehud and Taler, Michal and Shoenfeld, Yehuda and Gurevich, Michael and Sonis, Polina and Weisman, Omri and Weizman, Abraham and Gothelf, Doron},
  title = {Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits},
  journal = {The Journal of Clinical Psychiatry},
  year = {2017},
  volume = {78},
  number = {9},
  pages = {e1219--e1225},
  doi = {10.4088/jcp.16m11207}
}
Kostenlos starten →